Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2016

01.02.2016 | Clinical Study

Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma

verfasst von: Katerina Deike, Benedikt Wiestler, Markus Graf, Caroline Reimer, Ralf O. Floca, Philipp Bäumer, Philipp Kickingereder, Sabine Heiland, Heinz-Peter Schlemmer, Wolfgang Wick, Martin Bendszus, Alexander Radbruch

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

We analyzed whether the combined visualization of decreased apparent diffusion coefficient (ADC) values and increased cerebral blood volume (CBV) in perfusion imaging can identify prognosis-related growth patterns in patients with newly diagnosed glioblastoma. Sixty-five consecutive patients were examined with diffusion and dynamic susceptibility-weighted contrast-enhanced perfusion weighted MRI. ADC and CBV maps were co-registered on the T1-w image and a region of interest (ROI) was manually delineated encompassing the enhancing lesion. Within this ROI pixels with ADC values <the 30th percentile (ADCmin), pixels with CBV values >the 70th percentile (CBVmax) and the intersection of pixels with ADCmin and CBVmax were automatically calculated and visualized. Initially, all tumors with a mean intersection greater than the upper quartile of the normally distributed mean intersection of all patients were subsumed to the first growth pattern termed big intersection (BI). Subsequently, the remaining tumors’ growth patterns were categorized depending on the qualitative representation of ADCmin, CBVmax and their intersection. Log-rank test exposed a significantly longer overall survival of BI (n = 16) compared to non-BI group (n = 49) (p = 0.0057). Thirty-one, four and 14 patients of the non-BI group were classified as predominant ADC-, CBV- and mixed growth group, respectively. In a multivariate Cox regression model, the BI-, CBV- and mixed groups had significantly lower adjusted hazard ratios (p-value, αBonferroni < 0.006) when compared to the reference group ADC: 0.29 (0.0027), 0.11 (0.038) and 0.33 (0.0059). Our study provides evidence that the combination of diffusion and perfusion imaging allows visualization of different glioblastoma growth patterns that are associated with prognosis. A possible biological hypothesis for this finding could be the interpretation of the ADCmin fraction as the invasion-front of tumor cells while the CBVmax fraction might represent the vascular rich tumor border that is “trailing behind” the invasion-front in the ADC group.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef
2.
Zurück zum Zitat Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466PubMedCrossRef Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466PubMedCrossRef
4.
Zurück zum Zitat Field K, Rosenthal M, Yilmaz M, Tacey M, Drummond KJ (2014) Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset. Asia Pac J Clin Oncol 10:153–161PubMedCrossRef Field K, Rosenthal M, Yilmaz M, Tacey M, Drummond KJ (2014) Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset. Asia Pac J Clin Oncol 10:153–161PubMedCrossRef
5.
Zurück zum Zitat Hartmann C, Hentschel B, Simon M et al (2013) Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 19:5146–5157PubMedCrossRef Hartmann C, Hentschel B, Simon M et al (2013) Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 19:5146–5157PubMedCrossRef
6.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, pp 33–52 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, pp 33–52
7.
Zurück zum Zitat Chawalparit O, Sangruchi T, Witthiwej T et al (2013) Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service. J Med Assoc Thai 96:1365–1373PubMed Chawalparit O, Sangruchi T, Witthiwej T et al (2013) Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service. J Med Assoc Thai 96:1365–1373PubMed
8.
Zurück zum Zitat Wang S, Zhou J (2012) Diffusion tensor magnetic resonance imaging of rat glioma models: a correlation study of MR imaging and histology. J Comput Assist Tomogr 36:739–744PubMedPubMedCentralCrossRef Wang S, Zhou J (2012) Diffusion tensor magnetic resonance imaging of rat glioma models: a correlation study of MR imaging and histology. J Comput Assist Tomogr 36:739–744PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Weber M, Henze M, Tuttenberg J et al (2010) Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Investig Radiol 45:755–768CrossRef Weber M, Henze M, Tuttenberg J et al (2010) Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Investig Radiol 45:755–768CrossRef
10.
Zurück zum Zitat Weber M, Zoubaa S, Schlieter M et al (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899–1906PubMedCrossRef Weber M, Zoubaa S, Schlieter M et al (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899–1906PubMedCrossRef
11.
Zurück zum Zitat Murakami R, Hirai T, Sugahara T et al (2009) Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 251:838–845PubMedCrossRef Murakami R, Hirai T, Sugahara T et al (2009) Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 251:838–845PubMedCrossRef
12.
Zurück zum Zitat Sottoriva A, Spiteri I, Piccirillo SGM et al (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 110:4009–4014PubMedPubMedCentralCrossRef Sottoriva A, Spiteri I, Piccirillo SGM et al (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 110:4009–4014PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106–1111PubMedCrossRef Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106–1111PubMedCrossRef
15.
Zurück zum Zitat Romano A, Calabria LF, Tavanti F et al (2013) Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. Eur Radiol 23:513–520PubMedCrossRef Romano A, Calabria LF, Tavanti F et al (2013) Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. Eur Radiol 23:513–520PubMedCrossRef
16.
Zurück zum Zitat Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMedCrossRef Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMedCrossRef
17.
Zurück zum Zitat Radbruch A, Bendszus M, Wick W, Heiland S (2010) Comment to: parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma: pitfalls in perfusion MRI in brain tumors : Tsien C, Galban CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L. Clin Neuroradiol 20:183–184PubMedCrossRef Radbruch A, Bendszus M, Wick W, Heiland S (2010) Comment to: parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma: pitfalls in perfusion MRI in brain tumors : Tsien C, Galban CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L. Clin Neuroradiol 20:183–184PubMedCrossRef
18.
Zurück zum Zitat Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P (1997) Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 16:187–198PubMedCrossRef Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P (1997) Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 16:187–198PubMedCrossRef
19.
Zurück zum Zitat Meyer CR, Boes JL, Kim B et al (1997) Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1:195–206PubMedCrossRef Meyer CR, Boes JL, Kim B et al (1997) Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1:195–206PubMedCrossRef
20.
Zurück zum Zitat Pluim JPW, Maintz JBA, Viergever MA (2003) Mutual-information-based registration of medical images: a survey. IEEE Trans Med Imaging 22:986–1004PubMedCrossRef Pluim JPW, Maintz JBA, Viergever MA (2003) Mutual-information-based registration of medical images: a survey. IEEE Trans Med Imaging 22:986–1004PubMedCrossRef
21.
Zurück zum Zitat Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE (2014) Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol 32:774–782PubMedCrossRef Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE (2014) Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol 32:774–782PubMedCrossRef
22.
Zurück zum Zitat Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7:134–153PubMedPubMedCentralCrossRef Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7:134–153PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Fujiwara S, Nakagawa KOU, Harada H et al (2007) Silencing hypoxia-inducible factor-1 · inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30:793–802PubMed Fujiwara S, Nakagawa KOU, Harada H et al (2007) Silencing hypoxia-inducible factor-1 · inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30:793–802PubMed
24.
Zurück zum Zitat Zagzag D, Lukyanov Y, Lan L et al (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Investig 86:1221–1232PubMedCrossRef Zagzag D, Lukyanov Y, Lan L et al (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Investig 86:1221–1232PubMedCrossRef
25.
Zurück zum Zitat Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275–282PubMedCrossRef Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275–282PubMedCrossRef
26.
Zurück zum Zitat St Croix B, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9:549–556PubMedCrossRef St Croix B, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9:549–556PubMedCrossRef
27.
Zurück zum Zitat McAuliffe MJ, Lalonde FM, McGarry D, Gandler W, Csaky K, Trus BL (2001) Medical image processing, analysis & visualization in clinical research. Computer-Based Medical Systems, pp 381–386 McAuliffe MJ, Lalonde FM, McGarry D, Gandler W, Csaky K, Trus BL (2001) Medical image processing, analysis & visualization in clinical research. Computer-Based Medical Systems, pp 381–386
28.
Zurück zum Zitat Rosset A, Spadola L, Ratib O (2004) OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17:205–216PubMedPubMedCentralCrossRef Rosset A, Spadola L, Ratib O (2004) OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17:205–216PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675PubMedCrossRef Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675PubMedCrossRef
Metadaten
Titel
Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma
verfasst von
Katerina Deike
Benedikt Wiestler
Markus Graf
Caroline Reimer
Ralf O. Floca
Philipp Bäumer
Philipp Kickingereder
Sabine Heiland
Heinz-Peter Schlemmer
Wolfgang Wick
Martin Bendszus
Alexander Radbruch
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1982-z

Weitere Artikel der Ausgabe 3/2016

Journal of Neuro-Oncology 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.